Endometrial immune cell ratios and implantation success in patients with recurrent implantation failure.


Journal

Journal of reproductive immunology
ISSN: 1872-7603
Titre abrégé: J Reprod Immunol
Pays: Ireland
ID NLM: 8001906

Informations de publication

Date de publication:
03 2023
Historique:
received: 30 09 2022
revised: 12 01 2023
accepted: 23 01 2023
pubmed: 6 2 2023
medline: 28 3 2023
entrez: 5 2 2023
Statut: ppublish

Résumé

The objective of this study was to compare the endometrial immune cells quantities and ratios during the mid-luteal phase between women with recurrent implantation failure (RIF) with successful and unsuccessful embryo implantation. For this purpose, endometrial biopsies from 116 women aged between 29 and 46 with history of RIF undergoing Assisted Reproductive Technology (ART) without endometrial pathologies were immunohistochemically stained for CD3 + T-cells, CD4 + T-helpers, CD8 + T-killers, CD14 + monocytes, CD68 + macrophages, CD56 + NK cells and CD79α+ B-cells. Endometrial immune cells quantities and ratios were compared based on the embryo implantation outcome in the subsequent embryo transfer cycle. Spearman correlation analysis and Mann-Whitney U test were used to analyse the obtained data. Patients who experienced successful implantation at the subsequent cycle had significantly lower percentage of CD3 + T cells, and higher ratios of CD4 + /CD8 + , CD4 + /CD3 + and CD68 + /CD3 + than the patients who experienced another failure in implantation. In addition, the ratios of CD3 + /CD14 + , CD79α+ /CD14 + and CD56 + /CD14 + were significantly lower in the successful implantation group than that in the unsuccessful one. A cut off value of CD68 + /CD3 + ratio higher than 0.85 (AUC 0.67, 95% CI 0.56-0.79), CD4 + /CD3 + ratio higher than 0.19 (AUC 0.67, 95% CI 0.56-0.79) and CD4 + /CD8 + ratio higher than 0.43 (AUC 0.62, 95% CI 0.50-0.73) could be predictive factors for successful implantation in RIF patients. Knowledge on the immune cell composition could assist in the evaluation of the endometrial receptivity in RIF patients.

Identifiants

pubmed: 36739733
pii: S0165-0378(23)00022-0
doi: 10.1016/j.jri.2023.103816
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

103816

Informations de copyright

Copyright © 2023 Elsevier B.V. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The autors agree that they have no competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Rumiana Ganeva (R)

Research & Development Department, Nadezhda Women's Health Hospital, Sofia, Bulgaria; Department of Cell and developmental biology, Faculty of Biology, Sofia University "St. Kliment Ohridski", Sofia, Bulgaria. Electronic address: rum.ganeva@gmail.com.

Dimitar Parvanov (D)

Research & Development Department, Nadezhda Women's Health Hospital, Sofia, Bulgaria. Electronic address: dimparvanov@abv.bg.

Nina Vidolova (N)

Research & Development Department, Nadezhda Women's Health Hospital, Sofia, Bulgaria. Electronic address: nina.vidolova@abv.bg.

Margarita Ruseva (M)

Research & Development Department, Nadezhda Women's Health Hospital, Sofia, Bulgaria. Electronic address: margarita.ruseva@gmail.com.

Maria Handzhiyska (M)

Research & Development Department, Nadezhda Women's Health Hospital, Sofia, Bulgaria. Electronic address: mariavh@abv.bg.

Katarina Arsov (K)

Research & Development Department, Nadezhda Women's Health Hospital, Sofia, Bulgaria. Electronic address: kataarsov@hotmail.rs.

Ivon Decheva (I)

Research & Development Department, Nadezhda Women's Health Hospital, Sofia, Bulgaria. Electronic address: idecheva98@gmail.com.

Dimitar Metodiev (D)

Pathology Department, Nadezhda Women's Health Hospital, Sofia, Bulgaria. Electronic address: dr.dmetodiev@yahoo.com.

Veselina Moskova-Doumanova (V)

Department of Cell and developmental biology, Faculty of Biology, Sofia University "St. Kliment Ohridski", Sofia, Bulgaria. Electronic address: moskova@biofac.uni-sofia.bg.

Georgi Stamenov (G)

Obstetrics and Gynecology Department, Nadezhda Women's Health Hospital, Sofia, Bulgaria. Electronic address: g.stamenov1@abv.bg.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH